Company: NKLR
Filing Date: 2025-12-09
Form Type: S-1/A
Source: 0001213900-25-119411
Chunk: 75

Company: Terra Innovatum Global N.V.
Filing Date: 2025-12-09
Form: S-1/A
Chunk 75
---
 the Merger on October 9, 2025, we issued 8,000 preferred shares to former Terra Innovatum Global quotaholders and 40 preferred shares to Moonshot, which were contingently convertible into our ordinary shares at a ratio of 10,000 ordinary shares per preferred share upon meeting specified tranche conversion milestones and per the Merger Agreement and the Moonshot Agreement. On October 16, 2025, certain conversion milestones were met. In November 2025, our Board of Directors approved and executed the conversion of 4,020 of our preferred shares into 40,200,000 of our ordinary shares pursuant to the Merger Agreement. Following the conversion, our authorized capital is 540,200,000 ordinary shares and 4,020 preferred shares. Financial Performance For the three months ended September 30, 2025 and 2024, we reported a net loss of $2,987 and net income of $16, respectively. For the nine months ended September 30, 2025 and 2024, we reported a net loss of $5,580 and net income of $36, respectively. Net cash used in operating activities was $3,688 for the nine months ended September 30, 2025, and net cash provided by operating activities was $12 for the nine months ended September 30, 2024. As noted in our financial statements, we had an accumulated deficit of $5,617 as of September 30, 2025. Key Factors and Trends Affecting Our Business and Results of Operations We believe the following factors and trends may cause previously reported financial information not to be necessarily indicative of future operating results or future financial conditions:

| ● | Product          
 Development Plan |

The commercial rollout of any advanced nuclear reactors depends on securing regulatory approvals for its design, construction, and operation. Our regulatory engagement plan was submitted to the NRC, and the NRC is currently reviewing a number of safety related topics related to SOLO. Although our team has significant prior experience working with the NRC, we cannot control NRC’s review process and review periods may take longer than anticipated.

| ● | Macroeconomic                         
 Conditions and Global Market Dynamics |

Our business operates in a complex global environment with multiple interconnected economic factors that can significantly impact our technological development, regulatory trajectory, and potential market penetration. As a nuclear technology company with an international human capital strategy and multinational supply chain, we are sensitive to macroeconomic trends and risks.

| ● | Global Supply  
 Chain